HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Groups Offer Alternative Proposal For Modernized Cosmetics Regs

This article was originally published in The Rose Sheet

Executive Summary

The Personal Care Products Council and other members of the Safe Cosmetics Alliance agree that federal cosmetics regulations need updating, but they don’t agree that the Safe Cosmetics and Personal Care Products Act, introduced in March, is the answer. The industry groups outline their proposed changes in an April 9 statement.

You may also be interested in...



Safe Cosmetics Act Launches, Aimed At “Regulatory Black Hole”

House democrats Markey and Schakowsky have reintroduced The Safe Cosmetics and Personal Care Products Act. The legislation, backed by the Campaign for Safe Cosmetics, claims to close loopholes in federal law to ensure that consumers are not exposed to carcinogens and other hazardous substances through cosmetics use.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts

Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018484

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel